Eligible women had untreated breast cancer with breast tumors larger than 1.5 cm. After a biopsy, women were given VPA for 7 to 12 days, increasing from 30 mg/kg/d orally divided into two doses per ...
A team of researchers, affiliated with UNIST has proposed a satellite-aided drought monitoring method that can adequately represent the complex drought conditions into a single integrated drought ...
Presurgical evaluation of the AKT inhibitor MK-2206 in patients with operable invasive breast cancer. Background: Valproic acid (VPA) is a histone deacetylase (HDAC) inhibitor that increases apoptosis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results